SMAD4 antibody
GTX112980
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetSMAD4
Overview
- SupplierGeneTex
- Product NameSMAD4 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.58 mg/ml
- ConjugateUnconjugated
- Gene ID4089
- Target nameSMAD4
- Target descriptionSMAD family member 4
- Target synonymsDPC4, JIP, MADH4, MYHRS, mothers against decapentaplegic homolog 4, MAD homolog 4, SMAD, mothers against DPP homolog 4, deleted in pancreatic carcinoma locus 4, deletion target in pancreatic carcinoma 4, mothers against decapentaplegic, Drosophila, homolog of, 4
- HostRabbit
- IsotypeIgG
- Protein IDQ13485
- Protein NameMothers against decapentaplegic homolog 4
- Scientific DescriptionThis gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to TGF-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Shi YJ, Yang CG, Qiao WB, et al. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction. Eur J Pharmacol. 2023,961:176170. doi: 10.1016/j.ejphar.2023.176170Read this paper
- Chen HY, Chou HC, Ho YJ, et al. Characterization of TGF-β by Induced Oxidative Stress in Human Trabecular Meshwork Cells. Antioxidants (Basel). 2021,10(1). doi: 10.3390/antiox10010107Read this paper
- Gu J, Liu Y, Wu H, et al. Huangqi Shengmai Yin Protects against Radiation-Induced Cardiac Fibrosis Injury by Regulating the TGF-β1/Smads and MMPs. Evid Based Complement Alternat Med. 2019,2019:1358469. doi: 10.1155/2019/1358469Read this paper
- Huang SC, Wei PC, Hwang-Verslues WW, et al. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB. EMBO Mol Med. 2017,9(12):1660-1680. doi: 10.15252/emmm.201606914Read this paper
- Fang CY, Wu CC, Fang CL, et al. Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines. PLoS One. 2017,12(6):e0178960. doi: 10.1371/journal.pone.0178960Read this paper
- Khuman MW, Harikumar SK, Sadam A, et al. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats. Toxicology. 2016,374:29-41. doi: 10.1016/j.tox.2016.11.015Read this paper



![FACS analysis of K562 cells using GTX82787 SMAD4 antibody [4G1C6]. Green : SMAD4 Purple : negative control](https://www.genetex.com/upload/website/prouct_img/normal/GTX82787/GTX82787_20170912_FACS_w_23061322_714.webp)